ITP
At Meditalk, we are working in a research study being conducted by RTI Health Solutions (RTI-HS), on behalf of a pharmaceutical company.
About this study
At Meditalk, we are working in a research study being conducted by RTI Health Solutions (RTI-HS), on behalf of a pharmaceutical company. The purpose of this study is to learn about the experiences of individuals with immune thrombocytopenia or ITP in the UK and in the US. We will ask questions to better understand ITP symptoms, treatment goals and priorities, impact on quality of life, and ITP-related fatigue. To gather this information, RTI-HS will conduct interviews with up to 24 individuals. The online interview will last 60 minutes. As an appreciation for your time, you will be offered an incentive of 75GBP/ 90USD upon completion.
Eligibility check
You'll be asked to upload a brief proof of diagnosis (e.g. a prescription, hospital letter or test result).
Ready to take part?
Express interest in this study
Tap below to be taken back to the studies page where you can share your details with the research team.
Not on MediTalk yet? Create your free patient profile in 3 minutes and we'll match you to studies like this.